| scholarly article | Q13442814 |
| P50 | author | Hanne B. Rasmussen | Q55692664 |
| Thomas H. Bugge | Q64827087 | ||
| P2093 | author name string | Chen-Yong Lin | |
| Lotte K Vogel | |||
| Stine Friis | |||
| Jette Bornholdt | |||
| Sine Godiksen | |||
| Joanna Selzer-Plon | |||
| P2860 | cites work | Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells. Monoclonal antibody production, isolation, and localization | Q95823944 |
| Ichthyosis, follicular atrophoderma, and hypotrichosis caused by mutations in ST14 is associated with impaired profilaggrin processing | Q24321438 | ||
| The epidermal barrier function is dependent on the serine protease CAP1/Prss8 | Q24679139 | ||
| Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA | Q28116250 | ||
| Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk | Q28137768 | ||
| The emerging roles of serine protease cascades in the epidermis | Q28257226 | ||
| Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor | Q28505004 | ||
| Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes | Q28564911 | ||
| A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover | Q28571810 | ||
| Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis | Q33474548 | ||
| Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine | Q33732689 | ||
| Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation | Q34181560 | ||
| The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase-Prostasin serine protease cascade in cultured epithelial cells | Q35546542 | ||
| Biogenetic pathways of plasma membrane proteins in Caco-2, a human intestinal epithelial cell line | Q36223662 | ||
| Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. | Q36324873 | ||
| Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary | Q36753781 | ||
| Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. | Q36842289 | ||
| Zymogen activation, inhibition, and ectodomain shedding of matriptase | Q36991884 | ||
| Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea | Q37064596 | ||
| Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality | Q37197314 | ||
| Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition | Q37298015 | ||
| Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway | Q37362059 | ||
| Apical serine protease activity is necessary for assembly of a high-resistance renal collecting duct epithelium | Q39677927 | ||
| Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation | Q40230886 | ||
| An epithelial serine protease activates the amiloride-sensitive sodium channel | Q41086195 | ||
| Acute regulation of the epithelial sodium channel in airway epithelia by proteases and trafficking | Q41466710 | ||
| Protease inhibitors suppress the formation of tight junctions in gastrointestinal cell lines | Q41626064 | ||
| New therapeutic targets in ulcerative colitis: the importance of ion transporters in the human colon. | Q42672596 | ||
| Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis | Q44007860 | ||
| The ENaC channel is required for normal epidermal differentiation. | Q45989748 | ||
| Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides | Q46080677 | ||
| Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1. | Q46981327 | ||
| Altered ENaC expression leads to impaired sodium absorption in the noninflamed intestine in Crohn's disease. | Q52919538 | ||
| Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase. | Q53333977 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5793-5802 | |
| P577 | publication date | 2010-12-10 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase | |
| P478 | volume | 286 |
| Q36967340 | A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation |
| Q36115212 | Activity and inhibition of prostasin and matriptase on apical and basolateral surfaces of human airway epithelial cells |
| Q47748471 | Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity. |
| Q34722698 | Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes |
| Q37204613 | Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4 |
| Q35035059 | Detection of active matriptase using a biotinylated chloromethyl ketone peptide |
| Q36520143 | Early detection biomarkers for ovarian cancer |
| Q38673072 | Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality. |
| Q52778514 | HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase. |
| Q36735176 | Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase |
| Q51009956 | Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis |
| Q35979337 | Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation |
| Q41492870 | Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity |
| Q33749952 | Matriptase zymogen supports epithelial development, homeostasis and regeneration |
| Q37610695 | Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis |
| Q33948580 | Membrane-anchored serine proteases in vertebrate cell and developmental biology |
| Q36217915 | Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner |
| Q36760282 | Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway |
| Q39224627 | Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells |
| Q39523621 | Strong expression association between matriptase and its substrate prostasin in breast cancer |
| Q89679093 | The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane |
| Q37986624 | The matriptase-prostasin proteolytic cascade in epithelial development and pathology |
| Q34070450 | The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin |
| Q38753779 | The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction |
Search more.